Europe Non–Invasive Prenatal Testing market is set to touch US$ 500 Million by 2025.

The market is driven by number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards child bearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non–invasive techniques over invasive methods.

More Details @ http://www.dpiresearch.com/report-details.php?P_ID=145

“Europe Non–Invasive Prenatal Testing Market Research Report 2018” presents an in–depth assessment of the Europe non–invasive prenatal testing market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the market situation and future outlook. The research includes historic data from 2014 to 2017 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of country–based market. The report also includes assessment of comparative test analysis by companies. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Europe non–invasive prenatal testing market.

The superior geographic segments are identified in the report which studies NIPT test consumed and market revenue of the 15 countries. The countries included in this report are United Kingdom, Germany, Italy, Spain, France, Switzerland, Sweden, Belgium, Russia, Turkey, Netherland, Poland, Armenia, Moldova, Denmark from 2014 to 2017 and forecasts to 2025.

The report concludes with the profiles of major players in the Europe non–invasive prenatal testing market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolios and latest development and trends of the non–invasive prenatal testing market.

The major European companies dominating this market for its products, services and continuous product developments are:

Ariosa Diagnostics (Roche), LifeCodexx AG, Premaitha Health PLC and NIPD Genetics

Major and Promising NIPT Test Available in the European Region are:

• Panorama
• MaterniT21 PLUS
• Harmony
• Verifi
• NIFTY
• IONA
• PrenaTest
• Veracity

Major European Countries Analyzed Under This Report are:

• United Kingdom
• Germany
• Italy
• Spain
• France
• Switzerland
• Sweden
• Belgium
• Russia
• Turkey
• Netherland
• Poland
• Armenia
• Moldova
• Denmark

Major European NIPT Test Companies Analysis

• Ariosa Diagnostics (Roche)
• LifeCodexx AG
• Premaitha Health PLC
• NIPD Genetics

Key questions answered in this research report:

• At what pace is the NIPT test market growing in Europe? What will be growth trend in future?
• What are the key drivers and inhibitors in the current market? What will be the impact of
drivers and inhibitors in the future?
• What is the country revenue and forecast breakdowns? Which is the major country revenue
pockets for growth in the NIPT test market?
• What are the various NIPT test available in the European region and how they are poised to
grow?
• How is the market predicted to develop in the future?
• Who are the market players?